Gaucher disease: molecular heterogeneity and phenotype-genotype correlations
- PMID: 2502917
- PMCID: PMC1683351
Gaucher disease: molecular heterogeneity and phenotype-genotype correlations
Abstract
Gaucher disease (GD) is the most prevalent lysosomal storage disease. This autosomal recessive trait results from the defective activity of acid beta-glucosidase (beta-Glc). Four different exonic point mutations have been identified as causal alleles for GD. To facilitate screening for these alleles, assays were developed using allele-specific oligonucleotide hybridization to amplified genomic DNA sequences. Specifically, intron bases flanking exons 5, 9, and 10 were determined, and conditions for PCR amplification of these exons were obtained. Two different procedures were developed to distinguish signals obtained from the structural beta-Glc gene exons and those from the pseudogene. These procedures were used to determine the distribution of all known GD alleles in a population of 44 affected patients of varying phenotypes and ethnicity. The high frequency of one of the exon 9 mutations in Ashkenazi Jewish GD type 1 patients was confirmed, and, in addition, this mutation was present in ethnically diverse non-Jewish type 1 GD patients. Homozygotes (N = 5) for this allele were midly affected older individuals, and this mutant allele was not found in any patient with neuronopathic disease. The exon 10 mutation was confirmed as the predominant allele in types 2 and 3 GD. However, several type 1 GD patients, including one of Ashkenazi-Jewish heritage, also were heterozygous for this allele. The presence of this allele in type 1 patients did not correlate with the severity of clinical symptoms. The second exon 9 mutation and the exon 5 mutation were rare, since they occurred only heterozygously either in one type 2 GD patient or in two related Ashkenazi-Jewish GD patients, respectively. Although most GD patients (38 of 44) had at least one of the known mutant alleles, 57% were heterozygotes for only one of these mutations. Fourteen percent of patients were negative for all mutations. A total of 73% of GD patients had at least one unknown allele. The varying clinical phenotypes and ethnic origins of these incompletely characterized patients suggest that multiple other GD alleles exist.
Similar articles
-
Gaucher disease: A G+1----A+1 IVS2 splice donor site mutation causing exon 2 skipping in the acid beta-glucosidase mRNA.Am J Hum Genet. 1992 Oct;51(4):810-20. Am J Hum Genet. 1992. PMID: 1415223 Free PMC article.
-
Gaucher disease type 1: cloning and characterization of a cDNA encoding acid beta-glucosidase from an Ashkenazi Jewish patient.DNA. 1988 Oct;7(8):521-8. doi: 10.1089/dna.1.1988.7.521. DNA. 1988. PMID: 3180993
-
Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease.Am J Hum Genet. 1998 Aug;63(2):415-27. doi: 10.1086/301969. Am J Hum Genet. 1998. PMID: 9683600 Free PMC article.
-
Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.Hum Mutat. 2000;15(2):181-8. doi: 10.1002/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S. Hum Mutat. 2000. PMID: 10649495 Review.
-
Gaucher disease: gene frequencies and genotype/phenotype correlations.Genet Test. 1997;1(1):5-12. doi: 10.1089/gte.1997.1.5. Genet Test. 1997. PMID: 10464619 Review.
Cited by
-
Identification of GM1-Ganglioside Secondary Accumulation in Fibroblasts from Neuropathic Gaucher Patients and Effect of a Trivalent Trihydroxypiperidine Iminosugar Compound on Its Storage Reduction.Molecules. 2024 Jan 17;29(2):453. doi: 10.3390/molecules29020453. Molecules. 2024. PMID: 38257371 Free PMC article.
-
Lysosome and Inflammatory Defects in GBA1-Mutant Astrocytes Are Normalized by LRRK2 Inhibition.Mov Disord. 2020 May;35(5):760-773. doi: 10.1002/mds.27994. Epub 2020 Feb 8. Mov Disord. 2020. PMID: 32034799 Free PMC article.
-
Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype.Sci Rep. 2019 Apr 3;9(1):5571. doi: 10.1038/s41598-019-41914-7. Sci Rep. 2019. PMID: 30944381 Free PMC article.
-
Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology.PLoS One. 2015 Mar 30;10(3):e0118771. doi: 10.1371/journal.pone.0118771. eCollection 2015. PLoS One. 2015. PMID: 25822147 Free PMC article.
-
Phenotypic and genotypic heterogeneity in gaucher disease: Implications for genetic counseling.J Genet Couns. 1994 Mar;3(1):13-22. doi: 10.1007/BF01414603. J Genet Couns. 1994. PMID: 24233795
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials